Stem cell therapy for chronic obstructive pulmonary disease / 中华医学杂志(英文版)
Chinese Medical Journal
; (24): 1535-1545, 2021.
Article
em En
| WPRIM
| ID: wpr-887611
Biblioteca responsável:
WPRO
ABSTRACT
Chronic obstructive pulmonary disease (COPD), characterized by persistent and not fully reversible airflow restrictions, is currently one of the most widespread chronic lung diseases in the world. The most common symptoms of COPD are cough, expectoration, and exertional dyspnea. Although various strategies have been developed during the last few decades, current medical treatment for COPD only focuses on the relief of symptoms, and the reversal of lung function deterioration and improvement in patient's quality of life are very limited. Consequently, development of novel effective therapeutic strategies for COPD is urgently needed. Stem cells were known to differentiate into a variety of cell types and used to regenerate lung parenchyma and airway structures. Stem cell therapy is a promising therapeutic strategy that has the potential to restore the lung function and improve the quality of life in patients with COPD. This review summarizes the current state of knowledge regarding the clinical research on the treatment of COPD with mesenchymal stem cells (MSCs) and aims to update the understanding of the role of MSCs in COPD treatment, which may be helpful for developing effective therapeutic strategies in clinical settings.
Texto completo:
1
Base de dados:
WPRIM
Assunto principal:
Qualidade de Vida
/
Doença Pulmonar Obstrutiva Crônica
/
Transplante de Células-Tronco
/
Células-Tronco Mesenquimais
/
Pulmão
Aspecto:
Patient_preference
Limite:
Humans
Idioma:
En
Revista:
Chinese Medical Journal
Ano de publicação:
2021
Tipo de documento:
Article